A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
CD47 is a cell surface molecule that inhibits phagocytosis of cells that express it by binding to its receptor, SIRPα, on macrophages and other immune cells. CD47 is expressed at different levels by neoplastic and normal cells. Here, to reveal mechanisms by which different neoplastic cells generate...
Main Authors: | Betancur, Paola A., Abraham, Brian J., Yiu, Ying Y., Willingham, Stephen B., Khameneh, Farnaz, Zarnegar, Mark, Kuo, Angera H., McKenna, Kelly, Kojima, Yoko, Leeper, Nicholas J., Ho, Po, Gip, Phung, Swigut, Tomek, Sherwood, Richard I., Clarke, Michael F., Somlo, George, Weissman, Irving L., Young, Richard A. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2017
|
Online Access: | http://hdl.handle.net/1721.1/110093 https://orcid.org/0000-0001-8855-8647 |
Similar Items
-
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
by: Paola A. Betancur, et al.
Published: (2017-04-01) -
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
by: Mark P. Chao, et al.
Published: (2020-01-01) -
RBC-Specific CD47 pruning confers protection and underlies the transient anemia in patients treated with anti-CD47 antibody 5F9
by: Chen, J, et al.
Published: (2018) -
Tolerating CD47
by: Jeffrey S. Isenberg, et al.
Published: (2024-02-01) -
CD47–SIRPα-targeted therapeutics: status and prospects
by: R. Maute, et al.
Published: (2022-03-01)